Blog

Karen Knudsen: Clinical trials are the most advanced form of cancer care

Karen E. Knudsen/LinkedIn

Feb 12, 2025, 16:49

Karen Knudsen: Clinical trials are the most advanced form of cancer care

Karen Knudsen, Executive Strategic Advisor and Immediate Past CEO of ACS, shared a post on LinkedIn by Jonathan Hirsch, adding:

“Clinical trials aren’t just research, they are the most advanced form of cancer care. Without them, we would not have seen a 34% reduction in cancer mortality over the last two decades. Access to clinical trials is key! Thank you Paradigm Health + CEO Roundtable on Cancer for hosting such an important discussion at JPM25.

My takeaways:

Investing in clinical research isn’t optional, it’s essential.
Access to clinical trials = access to life-saving interventions.
Technology is poised to increase ease and access

The next generation of cancer breakthroughs depends on sustained investment in clinical research. Let’s keep the research engine going and continue accelerating progress in cancer prevention, detection, treatment, and cure.”

“At JPM25, Paradigm Health and CEO Roundtable on Cancer hosted a dynamic panel discussion moderated by Kenneth C. Frazier, former CEO of Merck and Paradigm Health Board Member. Joining him were industry trailblazers:

Bob Bradway, CEO of Amgen
Karen Knudsen former CEO of the American Cancer Society and Paradigm Health advisor
Ashley Magargee, CEO of Genentech

Before an audience of nearly 100 C-level executives, the conversation spanned key areas, including patient care, regulatory frameworks, technology innovations, and advancing equity in clinical research. Thank you to our cohost Sean Khozin, and the PACT Collective team.

To learn more about the discussion and to see how Paradigm Health re-engineering clinical research for maximum impact, contact us today.”